• A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Pheochromocytoma and Paraganglioma
• A highly malignant succinate dehydrogenase A-deficient renal cell carcinoma with bone metastasis misdiagnosed as hereditary leiomyomatosis and renal cell carcinoma: A case report
• A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata
• A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata
• A new missense mutation c.1240A>G in fumarate hydratase gene leads to uterine leiomyoma associated hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in Chinese
• A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma
• A retrospective review of 48 individuals, including 12 families, molecularly diagnosed with hereditary leiomyomatosis and renal cell cancer (HLRCC)
• An Aggressive Clinical Presentation of Familial Leiomyomatosis Associated with a Fumarate Hydratase Gene Variant of Uncertain Clinical Significance
• Bilateral fumarate hydratase deficient renal cell carcinoma in a patient with hereditary leiomyomatosis and renal cell cancer syndrome
• Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit
• Case report: A healthy baby achieved after preimplantation genetic testing from an infertile woman with hereditary leiomyomatosis and renal cell cancer syndrome
• Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series
• Clinical Cancer Genetics: A guide for the pathologist
• Clinical characteristics and treatments of hereditary leiomyomatosis renal cell carcinoma: two case reports and literature review
• Clinical phenotype and genetic function analysis of a rare family with hereditary leiomyomatosis and renal cell carcinoma complicated with Birt-Hogg-Dube syndrome
• Clinicopathological and molecular features of hereditary leiomyomatosis and renal cell cancer-associated renal cell carcinomas
• Clinicopathological characterisation of renal cell carcinoma in young adults: a contemporary update and review of literature
• Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples
• Combined transthoracic echocardiography and contrast-enhanced ultrasonography to trace intravenous leiomyomatosis with intracardiac extension
• Comparison of 2SC, AKR1B10, and FH Antibodies as Potential Biomarkers for FH-deficient Uterine Leiomyomas
• Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer
• Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of hereditary Leiomyomatosis and renal cell cancer (HLRCC)
• Cutaneous Leiomyoma Mimicking a Keloid
• Detailed Morphologic and Immunohistochemical Characterization of Myomectomy and Hysterectomy Specimens From Women With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome (HLRCC)
• Diseases of Hereditary Renal Cell Cancers
• Dysphagia Unmasked: A Case Report of Esophageal Leiomyomatosis
• Esophageal Leiomyomatosis Complicated with Achalasia in a Child With Alport Syndrome
• Facial Features of Hereditary Cancer Predisposition
• Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights
• Familial syndromes associated with testicular and paratesticular neoplasms: a comprehensive review
• Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening
• Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome
• Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome
• Fumarate hydratase deficient uterine leiomyoma: a clinicopathological and molecular analysis of 80 cases
• Fumarate hydratase FH c.1431_1433dupAAA (p.Lys477dup) variant is not associated with cancer including renal cell carcinoma
• Fumarate hydratase gene germline variants and mosaicism associated with pheochromocytoma and paraganglioma
• Fumarate Hydratase is a Novel Gene for Familial Non-Medullary Thyroid Cancer
• Fumarate hydratase variant prevalence and manifestations among individuals receiving germline testing
• Fumarate Hydratase-Deficient Abdominal Wall Leiomyoma Presenting a Decade Post-Fumarate Hydratase-Deficient Uterine Leiomyoma Excision: An Incidental or Syndromic Association?
• Fumarate hydratase-deficient renal cell carcinoma: A clinicopathological study of seven cases including hereditary and sporadic forms
• Fumarate hydratase-deficient renal cell carcinoma: an oncology care institutional experience
• Functional Characterization of <em>FH</em> Mutation c.557G&gt;A Underlies Uterine Leiomyomas
• Gene expression analysis in peripheral blood cells of patients with hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC): identification of NRF2 pathway activation
• Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome
• Genotypic and Phenotypic Characteristics of Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Korean Patients
• Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling
• Hemangioblastoma in Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: a phenotypic overlap between VHL and HLRCC Syndromes
• Hereditary leiomyomatosis and acute lymphoblastic leukemia: A link through fumarate dyshydratase mutation?
• Hereditary Leiomyomatosis and Renal Cell Cancer
• Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome in a young patient presenting with a large uterus: A case report and review of the literature
• Hereditary leiomyomatosis and renal cell cancer (HLRCC): A case report
• Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature
• Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree
• Hereditary leiomyomatosis and renal cell cancer without cutaneous manifestations in two Japanese siblings
• Hereditary Leiomyomatosis and Renal Cell Cancer-Recognizing Patterns May Save Lives
• Hereditary Leiomyomatosis and Renal Cell Cancer: A Case Report of Pilar Leiomyomatosis with History of Kidney Cancer and Review of the Literature
• Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals
• Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions & atypical fibroids
• Hereditary leiomyomatosis and renal cell cancer: Cutaneous lesions &amp; atypical fibroids
• Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening
• Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses
• Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report and implications of early onset
• Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review
• Hereditary leiomyomatosis and renal cell carcinoma: Case report and review of the literature
• Hereditary leiomyomatosis syndrome associated with renal cell carcinoma. A case report
• Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use
• Hereditary Renal Cancer Syndromes
• Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management
• How a woman's myomectomy saved her father's life: evidence of fumarate hydratase-deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
• Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
• Imaging evaluation of hereditary renal tumors: a pictorial review
• Imaging findings of hereditary renal tumors, a review of what the radiologist should know
• In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T &gt; G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma
• In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma
• Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair
• Malignant tumors in tuberous sclerosis complex: a case report and review of the literature
• Morphological clues to the appropriate recognition of hereditary renal neoplasms
• Multiple and hereditary renal tumors: a review for radiologists
• Multiple cutaneous and uterine leiomyomatosis: Reed's syndrome
• New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
• Next generation immunohistochemistry: Emerging substitutes to genetic testing?
• Novel FH mutation associated with multiple uterine leiomyomas in Chinese siblings
• Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
• Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
• Pathologic Oxidation of PTPN12 Underlies ABL1 Phosphorylation in Hereditary Leiomyomatosis and Renal Cell Carcinoma
• Prospective Detection of Germline Mutation of Fumarate Hydratase in Women With Uterine Smooth Muscle Tumors Using Pathology-based Screening to Trigger Genetic Counseling for Hereditary Leiomyomatosis Renal Cell Carcinoma Syndrome: A 5-Year Single Institut
• Recognizing Hereditary Renal Cancers Through the Microscope: A Pathology Update
• Renal cell carcinoma in young FH mutation carriers: case series and review of the literature
• Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
• Segregation, immunohistochemical, molecular and functional analyses classify a novel missense variant in fumarate hydratase (FH) as pathogenic
• The preliminary outcome of the combination of immunotherapy and targeted therapy after recurrence and metastasis for hereditary leiomyomatosis and renal cell cancer-a case report
• The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms
• The spectrum of clinical and genetic findings in hereditary leiomyomatosis and renal cell cancer (HLRCC) with relevance to patient outcomes: a retrospective study from a large academic tertiary referral center
• Treatment Strategies for Hereditary Kidney Cancer: Current Recommendations and Updates
• Unusual Cutaneous Lesions in a 53-Year-Old Female: A Potential Indicator of Underlying Renal Cell Carcinoma
• Update on Hereditary Renal Cancer and Imaging Implications
• Uterine leiomyoma with fumarate hydratase deficiency: A case report
• Uterine leiomyomas in hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome can be identified through distinct clinical characteristics and typical morphology
• Uterine leiomyomatosis in adolescents and young adults (AYAs) may represent a narrow phenotypic variant of FH tumour predisposition syndrome
• Uterine Mesenchymal Tumors: Hereditary Aspects